Category Archives: Jamjoom Pharma News

Jamjoom Pharma Strikes Strategic Deal with Bio-Thera for securing Cosentyx® Biosimilar in MENA

Jamjoom Pharma Strikes Strategic Deal with Bio-Thera for securing Cosentyx® Biosimilar in MENA Jeddah, Saudi Arabia –15 September, 2025 – Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma), one of the fastest-growing pharmaceutical companies in the Middle East and Africa, announced the signing of a strategic commercialization agreement with Bio-Thera Solutions, Ltd. (688177:SH), a global biopharmaceutical company…

New Agreement Brings Breakthrough Dyslipidemia Treatment to Saudi Arabia and MEA

New Agreement Brings Breakthrough Dyslipidemia Treatment to Saudi Arabia and MEA JEDDAH, July 30, 2025 – Jamjoom Pharma, a leading Saudi pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products across MEA, and Althera Laboratories, a company dedicated to developing and commercializing…

More Than Skin Deep: A New Partnership to Ease the Hidden Burden of Eczema in the UAE

More Than Skin Deep: A New Partnership to Ease the Hidden Burden of Eczema in the UAE Jamjoom Pharma and the Emirates Dermatology Society Join Forces to Launch “ECZPLORE” – A National Awareness Initiative to Help Families Lead an Eczema-Friendly Life Abu Dhabi on July 7h, 2025, Eczema, often dismissed as “just a skin problem,”…